Abstract:
ObjectiveTo investigate the effects of paclitaxel long-circulating nanomicelles combined with vMIP-Ⅱ-N-terminal peptide(NT21MP) on drug resistance of paclitaxel-resistant brest cancer MCF-7/PR cells.
MethodsSulforhodamine B(SRB) staining was used to detect the survival rate of breast cancer paclitaxel-resistant cell line MCF-7/PR.Cell scratch and Transwell assay were used to detect the effects of paclitaxel nanomicelles combined with NT21MP on the migration and invasion of paclitaxel-resistant cells.Flow cytometry was used to analyze the apoptosis and cell cycle.Western blotting was used to detect the expression of apoptosis, drug resistance and EMT-related proteins.
ResultsCompared with paclitaxel group, the paclitaxel nanomicelles could effectively inhibit the cell proliferation, migration and invasion, the expression levels of apoptotic proteins Bax and caspase3 were up-regulated, the expression levels of anti-apoptotic proteins Bcl-2 were down-regulated, the expression levels of MRP, P-GP and EMT-related proteins Vimentin and Slug were down-regulated, and the expression levels of E-cadherin were up-regulated(P < 0.01).Compared with the paclitaxel nanomicelles group, the paclitaxel nanomicelles combined with NT21MP group had more significant effects on the inhibition of cell proliferation, migration, invasion, cycle, anti-apoptosis and reversal paclitaxel resistance.
ConclusionsThe paclitaxel nanomicelles can effectively reverse the drug resistance of paclitaxel-resistant breast cancer cells, and the effects of the combination of paclitaxel manomicelles and NT21MP is more significant.